Assessing the Economic Value of a New Antidepressant
- 1 July 1995
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 8 (1), 34-45
- https://doi.org/10.2165/00019053-199508010-00006
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Health Care CBA/CEA: An Update on the Growth and Composition of the LiteratureMedical Care, 1993
- Some guidelines on the use of cost effectiveness league tables.BMJ, 1993
- Economic Analysis in Randomized Control TrialsMedical Care, 1992
- Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decisionmaking about health care programs.1991
- Economic evaluation in health care: Is there a role for cost-benefit analysis?Health Policy, 1991
- Efficacy of a reversible monoamine oxidase‐A inhibitor versus imipramine in subgroups of depressed patientsActa Psychiatrica Scandinavica, 1990
- Moclobemide, imipramine and placebo in the treatment of major depressionActa Psychiatrica Scandinavica, 1990
- Double-blind comparison of moclobemide, imipramine and placebo in depressive patientsActa Psychiatrica Scandinavica, 1990
- Risk Reduction From Low Osmolality Contrast Media: What Do Patients Think It is WorthMedical Care, 1990
- What do patients value? Willingness to pay for ultrasound in normal pregnancy.1985